| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9cb217f83556ce2a418344c2d485415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 |
| filingDate |
2000-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf67b9b459ef3c04b3889679ed20f261
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5b12ac0cb653438ec9983bde20ae93d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2626f7b0a531435a4371986edf51f11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7e6339ef2a2c4768678ea10e08729a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c80b295c041cca1f922825ac4ee271 |
| publicationDate |
2002-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1186607-A1 |
| titleOfInvention |
Optically active pyrrolopyridazine compounds |
| abstract |
[Invention] n An optically active pyrrolopyridazine derivative of the formula (I) or anpharmaceutically acceptable salt thereof:n n(wherein R 1 is alkyl; R 2 and R 3 are each independently alkyl; R 4 is optionallynsubstituted aryl; and A is imino, oxygen or sulfur). n [Utility] n The pyrrolopyridazine derivatives or pharmaceutically acceptable salts thereof ofnthe present invention exhibit excellent gastric acid secretory inhibition activity andngastric mucous membrane protection activity, as well as excellent antibacterialnactivity against Helicobacter pylori . They are useful medicines and particularly usefulnfor treating or preventing ulcerative diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1784403-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6734181-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7642269-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1784403-A1 |
| priorityDate |
1999-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |